Latest

Celestica: A Trifecta Of Growth, Margin Expansion And Improving Cash Flow Conversion (Archive)

Celestica delivers rare simultaneous strength in growth, margin expansion and cash flow conversion.

Meta: I Missed The Boat But Still Hesitant To Jump In Now (Archive)

Meta’s slowing ad momentum and regulatory wildcard temper otherwise attractive valuation support.

Pfizer: Why I'm Staying On The Sidelines (Archive)

Staying on the sidelines despite oncology progress and valuation discount.

Ares Capital: Bullish Due To Higher Deal Activity (Archive)

Bullish on Ares Capital as record deal flow and floating-rate mix drive upside potential.

Microsoft: Backdated Azure Growth And Pricing Discounts Make The Stock Less Attractive (Archive)

Pricing discounts threaten Azure and Copilot margins while Microsoft trades at peak valuations.

Google Says Don't Underestimate Me (Archive)

Evidence-based global equity insights to grow wealth with lower volatility and smarter risk.

Nvidia: Supplier-Led Blackwell Delays Can Push Out Production Timelines (Archive)

Supplier-driven Blackwell delays challenge near-term revenues but cheaper valuations support cautious neutrality.